What Researchers Did
French researchers reviewed the records of 18 patients treated from 2008 to 2021 who had chronic painful wounds that were not diabetic foot ulcers, and who had received hyperbaric oxygen therapy (HBOT) sessions, to see how their pain medicine use changed.
What They Found
In this retrospective study of 18 patients with chronic painful wounds, strong opioid use was lower after HBOT than before it (72.2 percent before versus 11.1 percent after, p = 0.005). A decrease in pain medicine step, dose or number was noted in 15 of 18 patients (83.3 percent), within a median of 3.5 months. Local improvement of the wound was also noted in 15 of 18 patients (83.3 percent), within a median of 3.9 months. The patients had calciphylaxis (6), vasculitis (4), hypertensive leg ulcer (3), mixed ulcer (3), Buerger's disease (1) and livedoid vasculitis (1). Analgesic use was followed for up to 12 months after HBOT.
What This Means for Canadian Patients
This was a single-center review of past records with no comparison group, so it cannot show that HBOT caused the drop in opioid use or the wound improvement. The authors describe HBOT as an add-on treatment in these painful wounds and say the finding needs to be shown in prospective, controlled studies. Patients with a painful chronic wound should talk with their own doctor about their options.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was retrospective, took place at one center, included only 18 patients with several different wound causes, and had no control group, so the authors call for prospective, controlled studies to confirm the findings.